DEVELOPING INNOVATIVE TECHNOLOGIES
THE TIME MACHINE LASER
Founded in November 2010 and registering on the OTC to become a public company in 2011, Medifirst Solutions, Inc. (Medifirst) trading under stock symbol MFST, develops innovative, non-invasive methods and technology for the healthcare marketplace. Its mission is to improve the quality of life for people who have exhausted traditional methods of treatments for chronic pain conditions. Medifirst’s flagship laser product, The Time Machine Infrared Laser (TML) helps people who suffer from pain, including joint pain, nerve pain, muscle pain, minor arthritis and similar ailments. In 2016, the company was granted USA FDA 510(k) medical device clearance to begin to market and sell its Infrared Laser in the U.S. to treat pain related conditions. Most lasers used by healthcare practitioners are for cosmetic use, and therefore we believe there is a significant market opportunity for our innovative hand-held Laser for pain related treatments. The U.S., as well as countries across the globe, is currently facing a critical opioid addiction crisis, one that has reached epidemic proportions. The need is greater than ever for effective natural and non-invasive means to help people who suffer from pain and chronic pain. Our corporate mission is to ameliorate and eliminate pain and suffering in people who have not yet started taking potentially addictive pain medications. Further, for those who are currently suffering addiction, we seek to provide a more successful chance of breaking that addiction by allowing them to end their dependency once their pain is no longer afflicting them.
Read all recent news announcements
MORE ABOUT US
THE INFRARED LASER
We are proud to present you with a revolutionary laser technology in a hand-held, mobile, battery operated and user-friendly medical device, for fast, non-invasive and effective treatments of pain, sports injuries, inflammation and much more.
Medifirst Solutions is dedicated to helping people everywhere who suffer from pain. The U.S., as well as countries across the globe, is currently facing a critical opioid addiction crisis, one that has reached epidemic proportions.
MEET THE TEAM
Management and company advisors have an average of over four decades of experience. We have brought on experienced advisors who have been actively involved in taking development stage companies to NASDAQ traded companies.